Grifols, S.A. (GRFS)
NASDAQ: GRFS · Real-Time Price · USD
7.10
-0.20 (-2.74%)
At close: May 9, 2025, 4:00 PM
7.10
0.00 (0.00%)
After-hours: May 9, 2025, 4:01 PM EDT
Grifols Employees
Grifols had 23,737 employees as of December 31, 2023. The number of employees decreased by 2,577 or -9.79% compared to the previous year.
Employees
23,737
Change (1Y)
-2,577
Growth (1Y)
-9.79%
Revenue / Employee
$314,572
Profits / Employee
$6,844
Market Cap
5.71B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 23,737 | -2,577 | -9.79% |
Dec 31, 2022 | 26,314 | 3,080 | 13.26% |
Dec 31, 2021 | 23,234 | -421 | -1.78% |
Dec 31, 2020 | 23,655 | -348 | -1.45% |
Dec 31, 2019 | 24,003 | 2,773 | 13.06% |
Dec 31, 2018 | 21,230 | 2,934 | 16.04% |
Dec 31, 2017 | 18,296 | 3,419 | 22.98% |
Dec 31, 2016 | 14,877 | 140 | 0.95% |
Dec 31, 2015 | 14,737 | 757 | 5.41% |
Dec 31, 2014 | 13,980 | 2,201 | 18.69% |
Dec 31, 2013 | 11,779 | 671 | 6.04% |
Dec 31, 2012 | 11,108 | -122 | -1.09% |
Dec 31, 2011 | 11,230 | 5,262 | 88.17% |
Dec 31, 2010 | 5,968 | -16 | -0.27% |
Dec 31, 2009 | 5,984 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
GRFS News
- 4 weeks ago - IBL International collaborates with Grifols on advanced biomarker panels - Business Wire
- 5 weeks ago - Brookfield resumes Grifols takeover talks, El Confidencial reports - Reuters
- 2 months ago - Grifols: Looking At The Longer-Term 2025-2027 Upside After No Sale - Seeking Alpha
- 2 months ago - Grifols expects to boost revenue and free cash flow, shares soar - Reuters
- 2 months ago - Grifols' sales rise over 10% in 2024, above target - Reuters
- 3 months ago - Blood Plasma Derivatives Market Insights and Forecast 2025-2030 - Grifols, SK Plasma, and Fusion Health Care Lead the Competition - GlobeNewsWire
- 4 months ago - Grifols Pioneers High-Tech Analysis of Plasma Bank to Detect Early Signs of Parkinson's Disease - GlobeNewsWire
- 4 months ago - Mason Capital complains about Grifols' transparency to Spanish regulator - Reuters